| CODE |
102113 |
| COMPONENT |
MIXED CHIMERISM POST SCT TRANSPLANTATION |
| UNITS |
% |
| CHECK DIGIT |
8 |
| PROPERTY |
Ratios |
| STATUS |
DEL |
| DATE LAST CHANGED |
2024-02-27 00:00:00 |
| CHANGE TYPE |
DEL |
| CHANGE REASON |
RELEASE 2.77: DEFINITIONDESCRIPTION: UPDATED TERM DEFINITION FOR MORE CONTEXT; STATUS: MAP TO 103156-6 DUPLICATE TERM; |
| TIME ASPECT |
POINT |
| SYSTEM |
Blood-peripheral |
| SCALE TYPE |
Quantitative |
| METHOD TYPE |
MOLGEN |
| CLASS |
BLDBK |
| FULLY SPECIFIED NAME |
MIXED CHIMERISM POST SCT TRANSPLANTATION:RATIO:PT:BLDP:QN:MOLGEN |
| SHORTNAME |
DEPRECATED MIXED CHIMERISM P SCT TRANSPLT BLDP-RTO |
| LONG COMMON NAME |
DEPRECATED MIXED CHIMERISM POST SCT TRANSPLANTATION [RATIO] IN PERIPHERAL BLOOD BY MOLECULAR GENETICS METHOD |
| EXAMPLE UCUM UNITS |
% |
| COMMENTS |
Transplantation is an effective treatment of many clinical disorders, but the me
chanisms that regulate immunological tolerance are uncertain and remain central
to improving patient outcome. Hemopoietic stem cell transplantation (SCT) often
establishes "mixed chimerism" in which immune cells from both the donor and pati
ent coexist in vivo in a setting of immunological tolerance. [PMID:30824417]
|
| MASTER ENTRY FOR VUID |
YES |
| VUID |
5370944 |
| EFFECTIVE DATE/TIME |
-
- 2023-12-20 00:00:00
- STATUS: ACTIVE
|
